Amedisys Inc posted an adjusted quarterly profit below estimates hurt by new Medicare regulations, and the home healthcare provider cut its 2011 earnings outlook. The company cut its full-year earnings forecast to $1.90-$2.00 a share from its earlier outlook of $2.20-$2.40. It backed its forecast for net service revenue of $1.47-$1.50 billion.
Analysts were looking for earnings of $2.30 a share, on revenue of $1.48 billion, according to Thomson Reuters I/B/E/S.
Amedisys also said Dale Redman will resign as chief financial officer on January 1 and Ronald LaBorde will replace him. Chief Operating Officer Mike Snow will quit and about 50 care centers will be closed, consolidated or sold.
Third-quarter net loss was $423 million, compared with a net income of $21.6 million. Excluding items, the company earned 36 cents a share. Net service revenue fell 6.5 pct to $374.9 million. Analysts on average had expected earnings of 50 cents a share, on revenue of $372 million.
The Baton Rouge, Louisiana-based company's shares, which have lost two-third of their value in one year, closed 6 percent down at $13.13 on Monday on Nasdaq. Currently, it is trading at $10.30, down 21% in midday trade.
StreetBeat Disclaimer
Analysts were looking for earnings of $2.30 a share, on revenue of $1.48 billion, according to Thomson Reuters I/B/E/S.
Amedisys also said Dale Redman will resign as chief financial officer on January 1 and Ronald LaBorde will replace him. Chief Operating Officer Mike Snow will quit and about 50 care centers will be closed, consolidated or sold.
Third-quarter net loss was $423 million, compared with a net income of $21.6 million. Excluding items, the company earned 36 cents a share. Net service revenue fell 6.5 pct to $374.9 million. Analysts on average had expected earnings of 50 cents a share, on revenue of $372 million.
The Baton Rouge, Louisiana-based company's shares, which have lost two-third of their value in one year, closed 6 percent down at $13.13 on Monday on Nasdaq. Currently, it is trading at $10.30, down 21% in midday trade.
StreetBeat Disclaimer
No comments:
Post a Comment